Tyligand Bioscience
PrivateLast Round
IPO
Jan 29, 2026
Est. Valuation
$222.2M
Total Funding Raised
$74.61M
Company Overview
Tyligand Bioscience is a biotechnology company that focuses on the discovery and development of innovative small molecule therapeutics and antibody-drug conjugates for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tyligand Bioscience Comparables
Compare Tyligand Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kumquat Biosciences | 83% | |
| BridgeBio Oncology | 83% | |
| Jacobio Pharmaceuticals Group Co Ltd | 81% | |
Tyligand Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jan 29, 2026 | ||||
| Series B | Apr 1, 2024 | ||||
| Series A Extension | Nov 1, 2022 | ||||
| Series A | Apr 1, 2021 | ||||
| Pre Seed | Sep 1, 2018 |
Tyligand Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ming Bioventures | Series A Extension |
| Medfine Capital | Pre Seed |
| Yijing Capital | Series A |
| 险峰K2VC | Pre Seed |
| Lilly Asia Ventures | Series B |
| Hongli Innovation Investment | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2024
$27M round led by Lilly Asia Ventures.
Tyligand Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tyligand Bioscience's valuation, stock price, and market status.